Tert-Butylamine

Tert-Butylamine

SCHEMBL910388

CC(C)(C)N.CC(C)(C)NC(=O)O

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEIDH1

The experimentally established mechanism targets of Tert-Butylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 3/20 0.36
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
EGFR P00533 1/20 0.33
TSHR P16473 1/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
CYP2C9 P11712 1/20 0.32
APEX1 P27695 1/20 0.32
NPC1 O15118 1/20 0.31
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9253 0.91
Carbamic Acid SCHEMBL8964476 0.88 ACHE (0.41) EPHX1MEN1KMT2APOLBALDH1A1
Ammonia Solution, Strong SCHEMBL1793738 0.88 EPHX1 (0.40) EPHX1MEN1KMT2APOLBALDH1A1
Hydrochloric Acid SCHEMBL9158754 0.88
Ammonia Solution, Strong SCHEMBL28082286 0.88
Water SCHEMBL6698331 0.88
Ethylenediamine SCHEMBL6467532 0.83 KDM4E (0.36) EPHX1MEN1KMT2APOLBALDH1A1
SCHEMBL10471874 0.81 ALDH1A1 (0.36) EPHX1MEN1KMT2APOLBALDH1A1
SCHEMBL10472483 0.79 EGFR (0.37) EPHX1MEN1KMT2APOLBALDH1A1
Succinamide SCHEMBL10471057 0.79 ALDH1A1 (0.35) EPHX1MEN1KMT2APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3284792-B1 METHOD FOR PREPARING CERAMIC INK COMPRISING METAL PRECURSOR AND CERAMIC PIGMENT AND CERAMIC INK MANUFACTURED BY THE SAME INKTEC CO LTD (KR) 2019-10-09 EP claimed
EP-2066497-B1 MANUFACTURING METHODS FOR METAL CLAD LAMINATES INKTEC CO LTD (KR) 2018-11-07 EP claimed
EP-2013298-B1 COMPOSITIONS FOR FORMING REFLECTING LAYER HAVING ORGANIC SILVER COMPLEXES,AND METHOD FOR PREPARING REFLECTING LAYER USING SAME INKTEC CO LTD (KR) 2018-06-27 EP claimed
EP-3284792-A1 METHOD FOR PREPARING CERAMIC INK COMPRISING METAL PRECURSOR AND CERAMIC PIGMENT AND CERAMIC INK MANUFACTURED BY THE SAME Inktec Co., Ltd. (KR) 2018-02-21 EP claimed
US-9786843-B2 Methods for fabricating an optoelectronic device INKTEC CO., LTD. (KR) 2017-10-10 US claimed
US-9556065-B2 Transparent conductive layer and preparation method thereof INKTEC CO., LTD. (KR) 2017-01-31 US claimed
EP-2003976-B1 USE OF AN ANTIBACTERIAL COMPOSITION CONTAINING ORGANIC SILVER COMPLEXES INKTEC CO LTD (KR) 2016-12-21 EP claimed
EP-2052043-B1 PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME INKTEC CO LTD (KR) 2016-10-12 EP claimed
US-9365935-B2 Etching solutions INKTEC CO., LTD. (KR) 2016-06-14 US claimed
EP-1846422-B1 ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS INKTEC CO LTD (KR) 2016-04-13 EP claimed
US-20090120800-A1 Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers INKTEC CO., LTD. (KR) 2009-05-14 US claimed
EP-2052043-A1 PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME Inktec Co., Ltd. (KR) 2009-04-29 EP claimed
US-20080277381-A1 Etching Solutions INKTEC CO., LTD. (KR) 2008-11-13 US claimed
US-20080206488-A1 Conductive Inks and Manufacturing Method Thereof INKTEC CO., LTD. (KR) 2008-08-28 US claimed
WO-2008103013-A1 CONDUCTIVE FIBERS AND A METHOD OF MANUFACTURING THE SAME INKTEC CO., LTD. (KR) 2008-08-28 WO claimed
JP-2008531810-A 2008-08-14 JP claimed
WO-2008018718-A1 PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME INKTEC CO., LTD. (KR) 2008-02-14 WO claimed
EP-1853671-A1 CONDUCTIVE INKS AND MANUFACTURING METHOD THEREOF Inktec Co., Ltd. (KR) 2007-11-14 EP claimed
WO-2007126277-A1 ALUMINUM WHEEL HAVING HIGH GLOSS INKTEC CO., LTD. (KR) 2007-11-08 WO claimed
WO-2006093398-A1 CONDUCTIVE INKS AND MANUFACTURING METHOD THEREOF INKTEC CO., LTD. (KR) 2006-09-08 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090120800-A1 Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers CA3, C9, CLTC EPHX1 4713/4885MEN1 695/4885KMT2A 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.